Gene therapy is a hot topic on Wall Street, with investors ready to bank on its future success. But could this recent investment bubble--$209 million since April 2013--be a repeat of the 1990s, in which a similar surge in investments in gene therapy companies came crashing down when the clinical results could not support the hype?...
More...